alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,701–6,725 of 7,816 matching trials · page 269 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])
NCT01496170
MK-8931; Placebo 		PHASE1
other		 COMPLETED 32 Merck Sharp & Dohme LLC
INDUSTRY		 2015-10-23
Antisocial Behavior on Healthcare Professionals in an Emergency Unit.
NCT02015884
Runs in: France · 1 site 		NA
other		 COMPLETED 58,465 Hospices Civils de Lyon
OTHER		 2015-10-23
CogStim, a Pilot Study : Cognitive Rehabilitation Management of HIV-1 Mild Cognitively Impaired Patients Controlled With Antiretroviral Therapy
NCT02343887
neuropsychological tests; STAI-Y scale for anxiety; Beck scale for ...
Runs in: France · 1 site 		NA
other		 UNKNOWN 60 Assistance Publique Hopitaux De Marseille
OTHER		 2015-10-23
The Women's Health Initiative Memory Study (The WHIMS Study)
NCT00685009
Estrogen hormone therapy; Estrogen plus progesterone hormone therap...
Runs in: United States · 1 site 		NA
other		 COMPLETED 7,525 National Heart, Lung, and Blood Institute (NHLBI)
NIH		 2015-10-19
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
NCT01436045
Insulin glulisine; Saline
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 12 HealthPartners Institute
OTHER		 2015-10-19
Postoperative Cognitive Dysfunction in Geriatric Patients
NCT00512200
Runs in: Switzerland · 1 site 		NA
other		 COMPLETED 280 University Hospital, Basel, Switzerland
OTHER		 2015-10-16
Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
NCT00776347
Donepezil; Donepezil
Runs in: Japan · 1 site 		NA
symptomatic-cholinergic		 COMPLETED 24 Osaka University
OTHER		 2015-10-15
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
NCT02246075
EVP-6124
Runs in: United States · 2 sites 		PHASE2
symptomatic-cholinergic		 WITHDRAWN 0 FORUM Pharmaceuticals Inc
INDUSTRY		 2015-10-15
Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI
NCT01046292
Ginkgo biloba
Runs in: Switzerland · 1 site 		PHASE4
other		 COMPLETED 50 University Hospital, Basel, Switzerland
OTHER		 2015-10-14
DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention for Primary Care - A Feasibility Study
NCT02159014
Facilitated group-based aerobic dance; Online, video prompted, indi...
Runs in: United Kingdom · 1 site 		NA
other		 COMPLETED 40 North Essex Partnership NHS Foundation Trust
OTHER_GOV		 2015-10-14
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
NCT00810147
BMS-708163; BMS-708163; BMS-708163; BMS-708163; Placebo
Runs in: Denmark; Finland; Sweden; United States · 41 sites 		PHASE2
other		 COMPLETED 209 Bristol-Myers Squibb
INDUSTRY		 2015-10-12
A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
NCT00890890
Avagacestat; Placebo
Runs in: Canada; Denmark; Finland; France; Sweden; United States · 64 sites 		PHASE2
other		 TERMINATED 263 Bristol-Myers Squibb
INDUSTRY		 2015-10-12
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
NCT01850238
AADvac1; Placebo
Runs in: Austria · 3 sites 		PHASE1
other		 COMPLETED 30 Axon Neuroscience SE
INDUSTRY		 2015-10-12
A Support Program for Carers of Persons With Dementia
NCT01287767
A multidimensional support program
Runs in: Norway · 1 site 		NA
other		 COMPLETED 230 Norwegian Centre for Ageing and Health
OTHER		 2015-10-07
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
NCT00065767
Raloxifene
Runs in: United States · 1 site 		PHASE2|PHASE3
other		 COMPLETED 20 University of Wisconsin, Madison
OTHER		 2015-10-05
Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease
NCT00478166
Runs in: United States · 1 site 		NA
other		 COMPLETED 206 University of Wisconsin, Madison
OTHER		 2015-10-05
Evaluation of Programs of Coordinated Care and Disease Management
NCT00627029
Care Coordination
Runs in: United States · 15 sites 		NA
other		 UNKNOWN 18,277 Mathematica Policy Research, Inc.
OTHER		 2015-10-01
Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research
NCT01049555
Actigraphy and video recording signal
Runs in: France · 1 site 		NA
other		 COMPLETED 42 Centre Hospitalier Universitaire de Nice
OTHER		 2015-09-30
Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
NCT02563418
Eye-tracking
Runs in: France · 1 site 		NA
other		 UNKNOWN 60 University Hospital, Angers
OTHER_GOV		 2015-09-30
Yoga for Family Caregivers of Alzheimers Disease Patient
NCT02563483
yoga and compassion meditation program 		NA
other		 COMPLETED 46 Federal University of São Paulo
OTHER		 2015-09-30
Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
NCT00446485
Ginkgo biloba standardized extract 24/6; Ginkgo Biloba standardized...
Runs in: Croatia · 1 site 		PHASE4
other		 COMPLETED 90 Milsing d.o.o.
OTHER		 2015-09-28
Safety and Efficacy of MT-4666
NCT01764243
MT-4666; Placebo
Runs in: Japan · 1 site 		PHASE2
other		 COMPLETED 450 Tanabe Pharma Corporation
INDUSTRY		 2015-09-28
Evaluation of Reader Training Processes
NCT02051790
florbetapir F 18
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 241 Avid Radiopharmaceuticals
INDUSTRY		 2015-09-28
A Study of V950 in People With Alzheimer Disease (V950-001 AM7)
NCT00464334
V950; ISCOMATRIX™; Placebo to V950 		PHASE1
other		 COMPLETED 86 Merck Sharp & Dohme LLC
INDUSTRY		 2015-09-25
Functional Imaging of Social Cognition in Premanifest Huntington's Disease
NCT02551705
functional Imaging 		NA
other		 UNKNOWN 40 Universitaire Ziekenhuizen KU Leuven
OTHER		 2015-09-16

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →